Quay Pharmaceuticals is a contract pharmaceutical Chemistry, Manufacturing and Control (CMC) company. The company can manufacture and QP release clinical materials into the EU under an IMP licence. It is also FDA registered. Quay has particular expertise in developing product for orally-administered APIs which are poorly water souble or show poor bioavailablity. Analytical services are also provided. The company operates in fully accredited EU GMP facilities and can therefore manufacture, QC and release for clinical trials. Quay performs parallel developmental and ICH stability testing of pharmaceutical products.